CME Group Inc. (CME)
My Picks To Monetize Today's Market Chaos
CME Group, Miami International Holdings, and Western Midstream Partners are my top picks for navigating current market volatility. CME and MIAX offer exposure to volatility-driven trading volumes, with CME providing reliable income and MIAX delivering high-growth potential through market share gains. WES stands out as a stable, high-yield income grower in the Permian Basin, with an 8.4% yield and robust free cash flow coverage.
CME Group's Strength Is Clear, But The Stock Looks Fully Valued
CME Group remains a Hold; shares reflect robust fundamentals but limited near-term upside at 25x forward earnings. CME posted record annual revenue and earnings, with Q4 operating margins near 67% and strong trading volumes in key segments. Recent fee hikes and product innovations provide incremental growth, but future returns hinge on sustained trading activity.
CME Group: Quality Shines Through, But It Doesn't Mean To Buy
CME Group delivered strong Q4 results with revenue up to $1.65B and expanding profit margins. Equity index, metals, and agricultural commodity contracts drove robust fee revenue growth; market data services revenue rose 14.5%. Despite operational excellence and new product launches, CME trades at lofty valuation multiples versus peers, warranting caution.
CME Group Q4 Earnings and Revenues Top Estimates, ADV Rises Y/Y
CME's Q4 earnings and revenues beat estimates as clearing fees and record ADV lift results, with EPS up nearly 10% year over year.
CME Group Inc. (CME) Q4 2025 Earnings Call Transcript
CME Group Inc. (CME) Q4 2025 Earnings Call Transcript
Compared to Estimates, CME (CME) Q4 Earnings: A Look at Key Metrics
The headline numbers for CME (CME) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
CME Group (CME) Q4 Earnings and Revenues Top Estimates
CME Group (CME) came out with quarterly earnings of $2.77 per share, beating the Zacks Consensus Estimate of $2.75 per share. This compares to earnings of $2.52 per share a year ago.
Curious about CME (CME) Q4 Performance? Explore Wall Street Estimates for Key Metrics
Evaluate the expected performance of CME (CME) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
CME Group (CME) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
CME (CME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CME Group Trades Above 50- and 200-Day SMA: How to Play the Stock?
CME trades above its 50- and 200-day SMAs, signaling momentum, as analysts see a $294 target and modest upside backed by strong cash flow.
Key factors for investors seeking relative value in precious metals in 2026 – CME Group's Norland
Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.
CME to launch cash-settled 100-ounce silver futures targeting retail investors
Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.
